Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834561
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Granisetron 1 mg Tablets Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00834717
- Locations
- 🇨🇦
Pharma Medica Research Inc., Toronto, Ontario, Canada
Azithromycin 600 Mg Tablets, Fed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00834132
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting
- Conditions
- Healthy
- Interventions
- Drug: OMNICEF® for oral suspension 250 mg/5mL
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835549
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 100
- Registration Number
- NCT00835588
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions
- Conditions
- Healthy
- Interventions
- Drug: UNIRETIC® 15/25 mg tablets
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00834067
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-02-03
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 50
- Registration Number
- NCT00835393
- Locations
- 🇺🇸
Gateway Medical Research, Inc., St. Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting
- Conditions
- Healthy
- Interventions
- Drug: 5 mg/500 mg Glipizide Metformin Hydrochloride TabletsDrug: 5 mg/500 mg METAGLIP™ Tablets
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00834587
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
🇺🇸PRACS Institute Ltd., East Grand Forks, Minnesota, United States
5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting
- Conditions
- Healthy
- Interventions
- Drug: 5 mg/500 mg Glipizide Metformin Hydrochloride TabletsDrug: 5 mg/500 mg METAGLIP™ Tablets
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00835497
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
🇺🇸PRACS Institute Ltd., East Grand Forks, Minnesota, United States
Desmopressin Acetate 0.2 mg Tablets, Fasting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-09-11
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 48
- Registration Number
- NCT00835211
- Locations
- 🇨🇦
MDS Pharma Sercives, St. Laurent, Quebec, Canada